Shingles is a painful rash caused by the varicella-zoster virus (VZV). VZV is the same virus that causes chickenpox. After a person is infected with chickenpox and recovers, the virus stays inactive in nerves. It can reactivate much later, causing shingles.
“Herpes zoster” is another name for shingles. This is because VZV belongs to a group of viruses called “herpesviruses.” The other name for VZV is “human herpesvirus 3.” It’s important to note that VZV does not cause genital herpes.
There are about 1 million cases of shingles each year in the U.S. Shingles is so common that about 1 in 3 adults in the U.S. will get it in their lifetime.
Here we’ll discuss the clinical features of shingles, when you should see a healthcare provider, and if the shingles vaccine is right for you.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) is now $0 for almost everyone*
Get SHINGRIX at the pharmacy or in-network doctor’s office today. 98% of privately insured people pay $0 and all Medicare Part D beneficiaries pay $0 at the pharmacy.
Prescribing Information
*Coverage and cost may vary and are subject to change without notice. Reimbursement decisions are made by individual insurance plans.
SHINGRIX is an FDA-approved vaccine for the prevention of shingles (herpes zoster) in adults 50 years and older. SHINGRIX is not used to prevent chickenpox.
• You should not receive SHINGRIX if you are allergic to any of its ingredients or had an allergic reaction to a previous dose of SHINGRIX
• An increased risk of Guillain-Barré syndrome (severe muscle weakness) was observed after vaccination with SHINGRIX
• Fainting can happen after getting injectable vaccines, including SHINGRIX. Precautions should be taken to avoid falling and injury due to fainting
• The most common side effects are pain, redness, and swelling at the injection site, muscle pain, tiredness, headache, shivering, fever, and upset stomach
• SHINGRIX was not studied in pregnant or nursing women. Tell your healthcare provider if you are pregnant, plan to become pregnant, or are breastfeeding
• Vaccination with SHINGRIX may not protect all individuals
• Ask your healthcare provider about the risks and benefits of SHINGRIX. Only a healthcare provider can decide if SHINGRIX is right for you
You are encouraged to report vaccine adverse events to the US Department of Health and Human Services. Visit www.vaers.hhs.gov to file a report, or call 1-800-822-7967.
For US audiences.
Trademarks are property of their respective owners.
©️2024 GSK or licensor.
PMUS-SGXWCNT240015 May 2024
Produced in the USA.
GoodRx Health information and resources are reviewed by our editorial staff with medical and healthcare policy and pricing experience. See our editorial policy for more detail. We also provide access to services offered by GoodRx and our partners when we think these services might be useful to our visitors. We may receive compensation when a user decides to leverage these services, but making them available does not influence the medical content our editorial staff provides.
The effects of shingles usually show up in three stages.
In the prodromal, or early stage, shingles typically starts off with burning, stabbing, or shooting pain on one side of the body or face. There can also be a tingling or itching feeling to the area.
Some people also have generalized symptoms such as:
Headache
Fatigue
Light sensitivity
Fever
Enlarged lymph nodes
This stage lasts 1 to 4 days.
Several days later, the infectious rash starts. The rash is typically very painful and looks like a collection of red, fluid-filled blisters. They follow a band, stripe, or belt-like pattern on one side of the body. The term “shingles” comes from the Latin word “cingulum,” which means belt or girdle.
Shingles can happen anywhere on the body, but it most commonly occurs on the torso. This stage lasts 7 to 10 days.
Healing begins in the third and final stage. The rash will slowly become less painful and start to dry and crust over. This stage usually lasts about 2 to 4 weeks.
As mentioned, varicella-zoster virus (VZV) causes shingles. After chickenpox, VZV lies asleep in sensory nerve fibers in the brain and spinal cord. Once the virus awakens, it travels down a single nerve and causes the characteristic rash and painful sensations along a “belt” of skin called a “dermatome.” Dermatomes are sections of skin that receive sensory supply by a single nerve.
Anyone who has had chickenpox before is at risk of developing shingles. But the risk of developing shingles increases as you age. Most people develop shingles after age 50. Half of all cases are in adults over 60 years old. This is because the immune system weakens with age.
Other risk factors for developing shingles include:
Cancers that decrease immunity
Cancer treatments, like chemotherapy
HIV infection
Immune-suppressing medications, such as those for autoimmune diseases and organ transplants
Increased stress from recent physical trauma
Family history
More research is needed to figure out whether psychological stress contributes to developing shingles:
Shingles treatment typically includes a combination of antiviral and pain medications.
Antiviral medications work best if you start them within 72 hours of when a shingles rash appears. This helps slow the virus from multiplying. Common antiviral medications for shingles include:
Acyclovir (Zovirax)
Valacyclovir (Valtrex)
Famciclovir (Famvir)
Over-the-counter pain medications — such as ibuprofen (Advil, Motrin), naproxen (Aleve), and acetaminophen (Tylenol) — are helpful. But if symptoms are more severe, you and your provider may consider stronger medications. This may include steroids (like prednisone) or opioid pain medications (like hydrocodone/acetaminophen or oxycodone). It’s important to note that opiate medications can lead to dependency and addiction and should be used with caution.
Complications can occur in some cases. So it’s important to get evaluated immediately if:
You have a higher risk of complications, such as older age (over 50) or a compromised immune state.
The blisters extend beyond one part of the body.
You have high fevers, which could suggest a bacterial infection.
The pain and rash occur on the face, especially near the eye. Shingles in the eye can affect vision and cause permanent blindness.
The rash involves the ear or causes facial paralysis, earaches, ringing in the ears, hearing loss, and/or room spinning (vertigo). This could suggest herpes-zoster oticus, or Ramsay Hunt syndrome, a rare condition where VZV reactivates in the facial nerve. It can cause some or all of the above symptoms.
The shingles vaccine (Shingrix) is currently recommended for adults ages 50 and older. This is even if you’ve had shingles in the past or received Zostavax, another shingles vaccine that’s no longer available in the U.S.
Shingrix helps to prevent shingles and complications from the disease. It produces an immune response that recognizes and fights against VZV once it reactivates. Researchers found the vaccine to be over 97% effective at preventing shingles in adults age 50 and older.
The Advisory Committee on Immunization Practices does not recommend a shingles vaccine for anyone under 50 years old at this time.
Most cases of shingles last 2 to 5 weeks. But, in some cases, pain can persist for months. This is called “postherpetic neuralgia,” and it’s the most common complication of shingles.
A person with shingles can’t pass shingles to another person, but they can pass VZV to someone who isn’t immune to chickenpox. This would be someone who has never had chickenpox or hasn’t received a vaccine against chickenpox. Providers often recommend that people with shingles avoid contact with babies or young children who haven’t been vaccinated.
The shingles rash is contagious, and it can spread VZV until it has dried and crusted over. It’s important to cover the rash to decrease the risk of spreading VZV.
Though a shingles rash will typically start to heal on its own, you should visit a healthcare provider for an evaluation within 3 days of getting a rash. This is because early treatment can help speed up healing and reduce pain. It’s also because treatment helps reduce the risk of complications.
Baxter, R., et al. (2018). Long-term effectiveness of the live zoster vaccine in preventing shingles: A cohort study. American Journal of Epidemiology.
Centers for Disease Control and Prevention. (2018). Shingles vaccination.
Centers for Disease Control and Prevention. (2020). Vaccines and preventable diseases.
Cunningham, A. L., et al. (2016). Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. The New England Journal of Medicine.
Cunningham, A. L., et al. (2018). Immune responses to a recombinant glycoprotein E herpes zoster vaccine in adults aged 50 years or older. The Journal of Infectious Diseases.
Curran, D., et al. (2018). Quality of life impact of a recombinant zoster vaccine in adults ≥ 50 years of age. The Journals of Gerontology.
Dooling, K. L., et al. (2018). Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. Morbidity and Mortality Weekly Report.
Kovac, M., et al. (2018). Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials. Vaccine.
Lal, H., et al. (2015). Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. The New England Journal of Medicine.
National Institute on Aging. (2021). Shingles.